1. Introduction {#s0005}
===============

The death of terminally differentiated cardiomyocytes is the leading cause of various cardiac diseases, including heart failure, myocardial infarction (MI) and ischemia/reperfusion (I/R) injury. Apoptosis and necrosis both contribute to myocardial cell death during the pathogenesis of cardiac diseases [@bib1], [@bib2]. Apoptosis has received much attention over the past 30 years because it was considered the only form of programmed cell death, although necrotic cell death is the central feature of the failing and I/R heart [@bib3], [@bib4]. Myocardial necrosis is an irreversible cell death process, accompanied by rapid loss of cellular membrane potential, which leads to cell swelling, rupture, cytolysis and subsequent inflammation [@bib5]. Increasing evidence suggests that several forms of necrosis are tightly regulated and programmed rather than merely an accidental form of cell death [@bib6], [@bib7]. Several signaling pathways have been shown to be involved in necrotic cell death [@bib8], [@bib9], [@bib10]. However, knowledge of the regulation of necrosis remains limited and further studies are needed to explore the central factors involved in the process.

The mitochondrial permeability transition pore (mPTP), a multiple protein complex, is the key effector in the pathway to cell death whose molecular components remain elusive [@bib11], [@bib12], [@bib13]. mPTP opening is the primary event of the mitochondrial intrinsic necrosis pathway, which is referred to as sudden mitochondrial permeability transition and loss of inner mitochondrial potential. The opening of mPTP leads to the interruption of mitochondrial respiration, matrix swelling and rupture of the mitochondrial membrane, which results in necrotic cell death [@bib12], [@bib13]. During cardiac I/R injury, necrosis induced by mPTP opening and the resulting mitochondrial damage is the main cause of myocardial cell death which contributes to more than 50% of the infarcted areas [@bib14]. Understanding the regulation of necrosis induced by mPTP opening is essential for cardio-protection during I/R injury.

CypD has been reported to be a central factor in the mitochondrial intrinsic necrosis pathway, which promotes the opening of mPTP. CypD-deficient cardiomyocytes have been shown to have strong resistance to H~2~O~2~ or Ca^2+^-induced necrosis. CypD-knockout in mice was also found to play a cardio-protective role during I/R injury [@bib15], [@bib16], [@bib17]. Cyclosporine A, a specific inhibitor of CypD, effectively prevents mPTP opening by binding to CypD and displacing it from the mPTP [@bib18], [@bib19]. Several lines of evidence suggest that CypD can also be regulated through protein-protein interaction or posttranslational modification [@bib20], [@bib21], [@bib22], [@bib23]. However, the precise mechanisms by which CypD/mPTP is regulated during necrosis remains largely unknown and further studies are required to understand these mechanisms.

Apoptosis repressor with caspase recruitment domain (ARC) is abundantly expressed in heart and muscle cells and has been reported to play a strong cardio-protective role during myocardial injury [@bib24]. Previous studies mainly showed its anti-apoptotic effects by either directly binding to caspase-2 and −8 or indirectly decreasing the mitochondrial Ca^2+^ [@bib25], [@bib26]. However, whether ARC is involved in the regulation of myocardial necrosis is still unknown.

ARC has been reported to inhibit necrosis in mouse L929 fibrosarcoma cells by participating in the extrinsic death receptor-mediated necrosis pathway [@bib27]. However, the cardio-protective effects of ARC depend on its mitochondrial localization during myocardial injury [@bib28], [@bib29]. The mitochondria is the convergence point for cell death signaling during the pathogenesis of cardiac diseases [@bib30]. The work presented in this study focused on the mitochondrial intrinsic necrosis pathway and the potential role of ARC in the regulation of myocardial necrosis.

p53 is a tumor suppressor gene that has been reported to be a major factor influencing cell death processes. p53 promotes cell death by directly interacting with death-related proteins or by acting as a transcription factor in the regulation of vast gene expression programs [@bib1]. It has been shown that p53 binds to the promoter region of ARC and decreases its expression at the transcriptional level at the initiation of apoptosis [@bib31]. It was previously reported that p53 regulates necrosis by targeting CypD which promotes mPTP opening in MEF cells [@bib23]. p53 is also a key mediator in myocardial cell death during I/R injury by influencing vast gene expression programs at the transcriptional level [@bib1], [@bib32]. However, whether p53 participates in myocardial necrosis remains largely unknown. Therefore, the specific role of the ARC and CypD/mPTP axis in the mitochondrial intrinsic necrosis pathway was explored in this study. Furthermore, we have also demonstrated the role of p53 in the ARC/CypD/mPTP axis at the transcriptional level during myocardial necrosis.

2. Materials and methods {#s0010}
========================

2.1. Cell culture and treatment {#s0015}
-------------------------------

H9c2 cells (American Type Culture Collection) were cultured in Dulbecco\'s modified Eagle\'s medium (Invitrogen, 12100046) supplemented with 10% fetal bovine serum, 100 U/ml penicillin, 100 µg/L streptomycin and 110 mg/L sodium pyruvate in a humidified atmosphere containing 5% CO~2~ at 37 °C. Cells were treated with 100 µM or 500 µM H~2~O~2~ at the indicated times.

2.2. Cell death assays {#s0020}
----------------------

The detailed procedures for PI staining are as follows: cardiomyocytes climbing to the carry sheet glass were washed with PBS three times after the H~2~O~2~ treatment. The concentration of working PI solution was 1.5 µM. Cells were then incubated on ice for 5 min. After washing with PBS three times, cells were fixed with 4% PFA on ice for 30 min. Following a quick wash, the cardiomyocytes were mounted with mounting medium containing DAPI and examined with a Nikon Eclipse Ti-S fluorescence microscope. The percentage of necrotic cell death was calculated by counting the total number of PI-positive nuclei divided by total DAPI-stained nuclei.

TUNEL assay was performed using TUNEL Apoptosis Detection Kit (Alexa Fluor 488, YEASEN, 40307ES20) according to the manufacturer\'s instructions. The percentage of apoptotic nuclei was calculated by counting the total number of TUNEL-positive nuclei divided by the total number of DAPI-stained nuclei.

2.3. Measurement of the lactate dehydrogenase (LDH) activity {#s0025}
------------------------------------------------------------

Twenty microliters of supernatant was collected from each cell culture well after H~2~O~2~ treatment and LDH activity was measured using the Spectrophotometric kit (Nanjing Jiancheng, Jiangsu, China) following the manufacturer\'s instructions.

2.4. Measurement of the mPTP dynamics {#s0030}
-------------------------------------

### 2.4.1. TMRE staining {#s0035}

TMRE at a working concentration of 20 nM was loaded into the cell culture pore and cultured with the cells for 30 min, and then the supernatant was discarded. After washing with PBS three times, the cells were immediately treated with 500 μM H~2~O~2~ and sequential cellular fluorescence images were acquired with a Leica TCS SP8 MP laser scanning confocal microscope.

### 2.4.2. Calcein-AM staining {#s0040}

The cells were trypsinized and resuspended in PBS, then loaded with calcein AM and cytosolic calcein fluorescence quencher (CoCl~2~) for 15 min at 37 °C. The cells were centrifuged, washed, and the cell pellets were resuspended in PBS and characterized for mitochondrial calcein fluorescence by flow cytometry analysis.

The cells were loaded with calcein-AM and a cytosolic calcein fluorescence quencher (CoCl~2~) for 30 min at 37 °C after the H~2~O~2~ treatment. Mitochondrial calcein fluorescence images were acquired with a Leica TCS SP8 MP laser scanning confocal microscope.

The fluorescence intensity was calculated as a percentage by gating upon the positive and negative controls.

2.5. Adenoviruses and vectors for gene overexpression {#s0045}
-----------------------------------------------------

Adenovirus ARC (Ad-ARC) and adenovirus h-galactosidase (Ad-β-gal) were as previously described [@bib31]. Adenovirus ARC^T149A^ (Ad-ARC^T149A^) was as previously described [@bib33]. Adenovirus p53 (Ad-p53) was as previously described [@bib31]. The CypD overexpression vector was constructed as follows: the CDS of CypD was cloned into the pKC-EF1α eukaryotic expression vector with an EF1α promoter.

The HA-ARC overexpression vector was constructed as follows: The CDS of ARC was cloned into the pKC-EF1α eukaryotic expression vector, the HA sequence was inserted into the C terminal of ARC; Myc-CypD was purchased from OriGene Company.

2.6. RNA interference (RNAi) {#s0050}
----------------------------

Adenovirus si-ARC (Ad-si-ARC) and the Adenovirus scr-ARC (Ad-scr-ARC) were as previously described [@bib31]. Adenovirus si-p53 (Ad-si-p53) and the Adenovirus scr-p53 (Ad-scr-p53) were as previously described [@bib31].

The CypD RNAi sense sequence was as follows:si-CypD-1: 5′ GCGACUUCACCAAUCACAATT 3′si-CypD-2: 5′ GCAUGUUGUGUUUGGCCAUTT 3′

The scramble sequence was as follows:scr-CypD: 5′ UUCUCCGAACGUGUCACGUTT 3′

2.7. Quantitative real-time PCR (qRT-PCR) {#s0055}
-----------------------------------------

The sequences of ARC primers were as follows:Forward, 5′-CGGAAACGGCTGGTAGAAAC-3′;Reverse, 5′-TGGCATGCTCACAGTTTGCT-3′

The sequences of IL-1β primers were as follows:Forward, 5′-TGATGACGACCTGCTAGTGT-3′;Reverse, 5′-CTTCTTTGGGTATTGTTTGG-3′;

The sequences of IL-6 primers were as follows:Forward, 5′-AGTTGCCTTCTTGGGACTGA-3′;Reverse, 5′-TGGGTGGTATCCTCTGTGAAG-3′;

The sequences of TNF-α primers were as follows:Forward, 5′-CACTAAGAATTCAAACTGGGGC-3′;Reverse, 5′-GAGGAAGGCCTAAGGTCCAC-3′.

2.8. Immunoblotting {#s0060}
-------------------

The cells were collected and lysed for 1 h on ice in a strong RIPA buffer containing a protease inhibitor cocktail (Merk, 539134). The samples were subjected to 12% sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis and transferred to PVDF (0.45 µm) membranes. The anti-ARC antibodies (1:2000) were from Abcam (ab126238) and Santa Cruz (sc-374177). The anti-CypD antibodies (1:2000) were from Abcam (ab110324). The anti-p53 antibody (1:1000) was from Cell Signaling Technology (mAb \#2524). The anti-α-actin antibody was from Santa Cruz Biotechnology. The anti-myc antibody was from Biorbyt, China. The anti-HA antibody was from Santa Cruz Biotechnology. Primary antibody was incubated at 4 °C overnight. After washing with PBS-Tween 20 five times, HRP-conjugated secondary antibodies were incubated at room temperature for 1 h. Bands were quantitated using Image J and α-actin was used as the loading control. Fold change was normalized to the indicated control.

2.9. Immunoprecipitation {#s0065}
------------------------

The cells were lysed on ice for 30 min in 500 μl NP-40 lysis buffer (50 mM Tris-HCl pH 8.0, 150 mM NaCl, 1 mM EDTA, 1% NP-40, 10% glycerol, 0.2 mM PMSF and Protease inhibitor). The lysates were precleared by centrifugation, and 50 μl of the samples was aliquoted for input. The remainder of the samples were immunoprecipitated with 2 μg of antibody and 50 μl of Protein-A/G PLUS-Agarose (Santa Cruz Biotechnology). The samples were rotated at 4 °C overnight. The beads were washed three times with 1 ml of low-salt NP40 lysis buffer (300 mM NaCl) and twice with 1 ml of high-salt lysis buffer (500 mM NaCl). The beads were then boiled for 10 min in the presence of 25 μl 2× sample buffer and the released proteins were fractionated in 12% SDS-PAGE gels. Proteins were detected by immunoblotting as described above.

2.10. Immunofluorescence staining {#s0070}
---------------------------------

The cells were fixed and permeabilized with 4% paraformaldehyde/0.1% Triton X-100 for 10 min at 4 °C, immediately prior to processing for immunofluorescence. Nonspecific antibody binding was blocked by a 30 min incubation period with 5% (v/v) fetal calf serum. The cells were then treated with ARC antibody (1:200) (Abcam, ab126238) for 2 h at room temperature. Following 3 washes, the cells were treated with Alexa Fluor 488 anti-rabbit secondary antibody (1:200) for 2 h at room temperature. The cells were then treated with CypD antibody (1:200) (Abcam, ab110324) for 2 h at room temperature. Following 3 washes, the cells were treated with Alexa Fluor 594 anti-rabbit secondary antibody (1:200) for 2 h at room temperature. Nuclei were identified by DAPI staining. Images were taken using a Nikon Eclipse Ti-S fluorescence microscope.

2.11. Mouse model of myocardial ischemia/reperfusion (I/R) injury {#s0075}
-----------------------------------------------------------------

All procedures were in agreement with the standards for care of laboratory animals as outlined in the NIH Guide for the Care and Use of Laboratory Animals. All procedures involving animals were reviewed and approved by the Institutional Animal Care and Use Committee of Qingdao University Medical College.

Mice were subjected to 30 min of LAD ligation followed by 3 h of reperfusion. The animals received PI injections of 10 mg/kg (PI; Sigma) to label necrotic cells after the termination of I/R surgery (n = 5/group). Frozen 5 µm sections were cut and counterstained with DAPI after which the quantification of necrotic cells was performed. Anti-a-actinin antibody was from Sigma, A7732. The immunofluorescence staining was performed as described above.

2.12. Detection of the pro-inflammatory factors {#s0080}
-----------------------------------------------

The I/R heart samples were harvested 24 h after I/R surgery and the pro-inflammatory factors were detected by Q-PCR analysis.

2.13. Masson trichrome staining for collagen {#s0085}
--------------------------------------------

Masson trichrome staining was performed using the staining kit (Solarbio, G1340) following the manufacturer\'s instructions. Cardiac fibrosis stained blue with Masson\'s trichrome. The ratio of fibrotic area was quantified using software (*Image J*) by an observer blinded to the sample identity.

2.14. Cardiac functional assays {#s0090}
-------------------------------

Left ventricular dimensions and cardiac function in mice exposed to I/R was analyzed by echocardiograph by an observer blinded to the sample identity two weeks after the I/R injury.

2.15. Statistical analysis {#s0095}
--------------------------

The results are expressed as the mean ± SEM of at least three independent experiments. The differences among experimental groups were evaluated by one-way ANOVA (analysis of variance). p \< 0.05 was considered statistically significant.

3. Results {#s0100}
==========

3.1. ARC attenuated H~2~O~2~-induced necrotic cell death in cardiomyocytes {#s0105}
--------------------------------------------------------------------------

Hydrogen peroxide (H~2~O~2~) induces both apoptosis and necrosis in cardiomyocytes and has been used to generate oxidative stress mimicking I/R injury [@bib8], [@bib17], [@bib34], [@bib35]. Our previous work, and the work of others, has shown that the response to oxidative stress induced by H~2~O~2~ in cardiomyocytes depends upon the concentration of H~2~O~2~ applied [@bib8], [@bib36]. Exposing the cardiomyocytes to lower concentrations of H~2~O~2~ (100 μM) mainly triggered apoptosis, while the higher concentration of H~2~O~2~ (500 μM) predominantly induced necrosis, as shown in [Supplementary Fig. 1A and Supplementary Fig. 1B](#s0160){ref-type="sec"}, which is consistent with previous results. Apoptosis and necrosis were respectively assessed by the terminal deoxynucleotidyl transferase (TdT)-mediated dUTP nick end labeling (TUNEL) assay and propidium iodide (PI) staining [@bib8], [@bib37]. To investigate the potential role of ARC in necrosis, cardiomyocytes were exposed to the higher concentration of H~2~O~2~ (500 μM), and the protein levels of ARC were examined during necrosis induced by oxidative stress. The protein levels of ARC showed a significant downregulation ([Fig. 1](#f0005){ref-type="fig"}A and [Supplementary Fig. 4A](#s0160){ref-type="sec"}). We then forced the expression of ARC in cardiomyocytes by adenoviral infection ([Fig. 1](#f0005){ref-type="fig"}B). Our results showed that the overexpression of ARC attenuated necrosis in cardiomyocytes exposed to H~2~O~2~ compared to the negative control group ([Fig. 1](#f0005){ref-type="fig"}C, D and [Supplementary Fig. 1C](#s0160){ref-type="sec"}). To mimic the H~2~O~2~-induced ARC downregulation, we knocked down the endogenous ARC in cardiomyocytes ([Fig. 1](#f0005){ref-type="fig"}E). Our results showed that the knockdown of ARC sensitized the cardiomyocytes to undergo necrosis after H~2~O~2~ exposure even at the lower concentration (100 μM) compared to the negative control ([Fig. 1](#f0005){ref-type="fig"}F and [Supplementary Fig. 1D](#s0160){ref-type="sec"}). Taken together, these results indicated that ARC could attenuate myocardial necrosis induced by oxidative stress as a result of H~2~O~2~ exposure.Fig. 1**Apoptosis repressor with CARD (ARC) inhibited H**~**2**~**O**~**2**~**-induced necrosis.** (A) ARC protein levels in cardiomyocytes treated with 500 μM H~2~O~2~ for the indicated time were detected by Western blotting. (B) Adenovirus could efficiently force the expression of ARC in cardiomyocytes. (C) Forced expression of ARC prevented H~2~O~2~-induced necrosis in cardiomyocytes exposed to 500 μM H~2~O~2~ for 12 h compared to the control. Necrosis was detected by PI assay; scale bar, 30 µm. (D) Statistical analysis of the proportion of the PI positive cells in each group. Error bars represent SEM. \*P \< 0.05 vs control. (E) Adenovirus could efficiently knockdown the endogenous ARC. (F) Knockdown of ARC increased H~2~O~2~-induced necrosis in cardiomyocytes exposed to 100 μM H~2~O~2~ for 12 h compared with the control. Necrosis was detected by PI assay; Error bars represent SEM. \*P \< 0.05 vs control.Fig. 1

3.2. ARC inhibited mPTP opening induced by H~2~O~2~ in cardiomyocytes {#s0110}
---------------------------------------------------------------------

We next sought to understand the mechanism by which ARC inhibited myocardial necrosis. The mitochondrial permeability transition is the primary component of oxidative damage-induced necrosis during cardiac I/R injury. We then examined whether ARC-based attenuation of H~2~O~2~-induced myocardial necrosis was due to the prevention of the mitochondrial permeability transition pore (mPTP) opening. The opening of the mPTP is determined by the loss of the inner-membrane potential (ΔΨ~m~). TMRE (tetramethylrhodamine ethyl ester) is a specific mitochondrial inner-membrane potential indicator and is widely used in the detection of ΔΨ~m~ during the induction of necrosis [@bib17], [@bib20], [@bib38]. The cardiomyocytes were loaded with TMRE (20 nM) and the opening of the mPTP was visualized as a rapid dissipation of TMRE fluorescence. Our results showed that the rapid loss of TMRE fluorescence in a time dependent manner was indicating the opening of mPTP in cardiomyocytes that were exposed to H~2~O~2~ ([Fig. 2](#f0010){ref-type="fig"}A). Conversely, treating cells with CsA (5 μM), the most specific inhibitor of mPTP opening [@bib39], could delay the loss of TMRE fluorescence ([Supplementary Fig. 2B](#s0160){ref-type="sec"}). These results demonstrated that the dissipation of fluorescence in cells exposed to H~2~O~2~ was the result of the pores opening. Next, we explored whether ARC was involved in the regulation of the mPTP opening in cardiomyocytes upon H~2~O~2~ exposure. We overexpressed ARC in cardiomyocytes successfully, as shown in [Fig. 1](#f0005){ref-type="fig"}B. The overexpression of ARC significantly delayed the TMRE loss in cardiomyocytes exposed to H~2~O~2~ compared to the negative control group indicating that ARC significantly inhibited mPTP opening during necrosis ([Fig. 2](#f0010){ref-type="fig"}B and C). To further confirm the specificity of these events on the pore dynamics, we utilized another established method to detect mPTP opening in the intact cells [@bib40], [@bib41]. We incubated cardiomyocytes with calcein-AM (1 μM) and cobalt-chloride (CoCl~2~, 1 mM), which localized calcein fluorescence in the mitochondria. The mPTP opening was determined by the reduction in calcein fluorescence in the mitochondria. Our results showed that H~2~O~2~-induced necrosis in cardiomyocytes could significantly induce loss of calcein fluorescence in the mitochondria compared to the negative control. Moreover, ARC overexpression in cardiomyocytes delayed the calcein fluorescence loss upon H~2~O~2~ exposure ([Fig. 2](#f0010){ref-type="fig"}D and E). Taken together, these results demonstrated that ARC could significantly inhibit mPTP opening in H~2~O~2~-induced necrosis in cardiomyocytes.Fig. 2**ARC prevented mPTP opening induced by 500 μM H**~**2**~**O**~**2**~. (A) Inner mitochondrial membrane potential (ΔΨ~m~) was detected by TMRE staining at the indicated time in cardiomyocytes exposed to 500 μM H~2~O~2~ or without any treatment. The intensity of TMRE fluorescence was measured by confocal microscopy. The relative TMRE fluorescence intensity was the ratio to the initial value. Error bars represent SEM. (B) Forced expression of ARC delayed the loss of TMRE fluorescence in cardiomyocytes exposed to 500 μM H~2~O~2~ compared to the control; Scale bar, 20 µm. (C) Statistical data showed the intensity of the TMRE fluorescence in each group. Error bars represent SEM. \*P \< 0.05 vs control. (D) Forced expression of ARC delayed the loss of calcein fluorescence intensity in cardiomyocytes exposed to 500 μM H~2~O~2~ compared to the control; scale bar, 10 µm. (E) Statistical data showed the intensity of the calcein fluorescence in each group. Error bars represent SEM. \*P \< 0.05 vs control.Fig. 2

3.3. Mitochondrial localization of ARC was essential for its role in the inhibition of H~2~O~2~-induced necrotic cell death {#s0115}
---------------------------------------------------------------------------------------------------------------------------

It has been reported that ARC suppresses TNF-α-induced necrosis in mouse L929 fibrosarcoma cells by interacting with TNFR and disrupting RIP1 recruitment in the cytoplasm [@bib27]. However, it is well known that ARC is mainly localized in the mitochondria [@bib42]. Our results also showed that ARC significantly inhibited mPTP opening in H~2~O~2~-induced necrosis in cardiomyocytes. Therefore, we hypothesized that ARC was involved in the mitochondrial intrinsic necrosis pathway. Our previous results showed that the phosphorylation of ARC at the T149 residue by CK2 is involved in the localization to mitochondria in cardiomyocytes, whereas the nonphosphorylated ARC is unable to migrate to the mitochondria and remains distributed in the cytoplasm [@bib28], [@bib43]. We forced the expression of the mutated form of ARC with T149 converted to a nonphosphorylatable alanine residue (A149) by the adenoviral infection. As shown in [Fig. 3](#f0015){ref-type="fig"}A and [Supplementary Fig. 4B](#s0160){ref-type="sec"}, the forced expression of ARC^T149A^ was mainly distributed in the cytoplasm which was consistent with the previous results [@bib28], [@bib43]. The normal ARC inhibited necrosis significantly compared to the control group, while mutated ARC^T149A^ could not inhibit necrosis in H~2~O~2~-exposed cardiomyocytes ([Fig. 3](#f0015){ref-type="fig"}B and C). Furthermore, the mutated ARC^T149A^ could not inhibit the opening of mPTP in H~2~O~2~-exposed cardiomyocytes ([Fig. 3](#f0015){ref-type="fig"}D). These results demonstrated that the role of ARC on the inhibition of H~2~O~2~-induced necrotic cell death was dependent on its mitochondrial localization.Fig. 3**Mitochondrial localization of ARC was essential for inhibition of H**~**2**~**O**~**2**~**-induced necrotic cell death.** (A) Different distributions of ARC^T149A^ in the cytosol and mitochondria. (B) Adenovirus could efficiently force the expression of ARC and ARC^T149A^ in cardiomyocytes. The forced expression of ARC prevented necrosis, while forced expression of ARC^T149A^ could not prevent necrosis in cardiomyocytes exposed to 500 μM H~2~O~2~ for 12 h. Necrosis was detected by PI assay (C) and indicated by LDH release assay (D). Error bars represent SEM. \*P \< 0.05 vs control. (E) Inner mitochondrial membrane potential (ΔΨ~m~) was detected by TMRE staining at the indicated time. Forced expression of ARC^T149A^ could not delay the loss of TMRE fluorescence intensity in cardiomyocytes exposed to 500 μM H~2~O~2~ compared with the control. Error bars represent SEM.Fig. 3

3.4. ARC inhibited H~2~O~2~-induced necrotic cell death by targeting CypD in cardiomyocytes {#s0120}
-------------------------------------------------------------------------------------------

Our results showed that ARC was localized to mitochondria and significantly inhibited mPTP opening during H~2~O~2~-induced myocardial necrosis. Next, we explored the ARC mechanism for the inhibition of mPTP opening. CypD is the main regulator of mPTP, which can promote the opening of mPTP and induce necrosis in cardiomyocytes [@bib44], [@bib45]. First, we forced the expression of CypD in cardiomyocytes using the eukaryon expression plasmid with the EF1α promoter to confirm its role in the induction of necrosis in cardiomyocytes ([Fig. 4](#f0020){ref-type="fig"}A). The overexpression of CypD sensitized cardiomyocytes to undergo necrosis when exposed to H~2~O~2~ (100 μM) ([Fig. 4](#f0020){ref-type="fig"}B and C). Then, we used siRNA to knockdown the expression of endogenous CypD in cardiomyocytes ([Fig. 4](#f0020){ref-type="fig"}D). Our results showed that the knockdown of CypD protected cardiomyocytes from necrosis induced by H~2~O~2~ exposure ([Fig. 4](#f0020){ref-type="fig"}E and F). CsA is the specific inhibitor which binds with CypD and antagonizes its activity [@bib16]. We found that treatment with CsA (5 μM) could also protect cardiomyocytes from necrosis induced by H~2~O~2~ ([Fig. 4](#f0020){ref-type="fig"}G and H). These results confirmed that CypD was involved in H~2~O~2~-induced myocardial necrosis.Fig. 4**CypD regulated H**~**2**~**O**~**2**~**-induced myocardial necrosis** (A) Forced expression of CypD using the eukaryon expression plasmid with EF1α promoter in cardiomyocytes. Forced expression of CypD sensitized cardiomyocytes to undergo necrosis when exposed to 100 μM H~2~O~2~ for 12 h compared with the control. Necrosis was detected by PI assay (B) and indicated by LDH release assay (C); error bars represent SEM. \*P \< 0.05 vs control. (D) CypD was knocked down by using the small interfering RNA. Knockdown of CypD prevented H~2~O~2~-induced necrosis in cardiomyocytes exposed to 500 μM H~2~O~2~ for 12 h compared with the control. Necrosis was detected by PI assay (E) and indicated by LDH release assay (F); error bars represent SEM. \*P \< 0.05 vs control. CsA (5 μM) treatment prevented H~2~O~2~-induced necrosis in cardiomyocytes exposed to 500 μM H~2~O~2~ for 12 h compared with the control. Necrosis was detected by PI assay (G) and indicated by LDH release assay (H). Error bars represent SEM. \*P \< 0.05 vs control.Fig. 4

Then, we sought to investigate whether ARC inhibited mPTP opening and necrosis by targeting the CypD protein. It has been reported that the interacting proteins regulate the activity of CypD [@bib20]. Our results showed that ARC colocalized with CypD in cardiomyocytes ([Fig. 5](#f0025){ref-type="fig"}A). We performed ectopic expression of HA-ARC and Myc-CypD in 293T cells and demonstrated that ARC could interact with CypD ([Fig. 5](#f0025){ref-type="fig"}B). We further confirmed the physical interaction between endogenous ARC and CypD by immunoprecipitation assay ([Fig. 5](#f0025){ref-type="fig"}C). Next, we explored whether ARC regulated myocardial necrosis by targeting CypD. Our results showed that the overexpression of ARC inhibited H~2~O~2~-induced necrosis compared to the control, whereas this inhibition was abolished by simultaneous overexpression of CypD ([Fig. 5](#f0025){ref-type="fig"}D). Moreover, the knockdown of ARC sensitized cardiomyocytes to undergo necrosis when exposed to H~2~O~2~ (100 μM) and this effect was also antagonized by the simultaneous knockdown of CypD ([Fig. 5](#f0025){ref-type="fig"}E and F). Furthermore, ARC could also inhibit necrosis induced by CypD overexpression in cardiomyocytes exposed to H~2~O~2~ (100 μM) as shown in [Fig. 5](#f0025){ref-type="fig"}G and H. Taken together, these results demonstrated that ARC inhibited necrosis by targeting CypD in cardiomyocytes.Fig. 5**ARC prevented mPTP opening and necrotic cell death by inhibiting the activity of CypD.** (A) Colocalization of ARC with CypD in cardiomyocytes was detected by immunofluorescence staining. ARC, green; CypD, red; nuclei, blue; scale bar, 10 µm. (B) Interaction of ARC with CypD was detected by immunoprecipitation in 293 T cells with ectopic expression of HA-ARC and Myc-CypD. (C) Interaction of endogenous ARC with CypD in cardiomyocytes was detected by immunoprecipitation. (D) Overexpression of ARC inhibited necrosis in cardiomyocytes, which was abolished by simultaneous overexpression of CypD in cardiomyocytes exposed to 500 μM H~2~O~2~ for 12 h. Necrosis was detected by PI assay. Error bars represent SEM; \*P \< 0.05 vs control. Knockdown of ARC sensitized cardiomyocytes to undergo necrosis which was inhibited by simultaneous knockdown of CypD in cardiomyocytes exposed to 100 μM H~2~O~2~ for 12 h. Necrosis was detected by PI assay (E) and indicated by LDH release assay (F). Error bars represent SEM; \*P \< 0.05 vs control. Forced expression of CypD sensitized cardiomyocytes to undergo necrosis which was abolished by simultaneous overexpression of ARC. Necrosis was detected by PI assay (G) and indicated by LDH release assay (H). Error bars represent SEM; \*P \< 0.05 vs control.Fig. 5

3.5. p53 promoted myocardial necrosis by transcriptionally repressing ARC expression {#s0125}
------------------------------------------------------------------------------------

As ARC was downregulated during the induction of necrosis, we explored the upstream regulator of ARC. In our previous work, we revealed that p53 could transcriptionally repress the expression of ARC during apoptosis induction [@bib31]. Another study showed that p53 mediated necrosis by targeting CypD in MEF cells [@bib23]. However, whether p53 is involved in myocardial necrosis remains largely unknown. The protein levels of p53 were significantly increased, which was conversely related to the decreased protein levels of ARC during necrosis induced by H~2~O~2~ in cardiomyocytes ([Fig. 6](#f0030){ref-type="fig"}A and [Fig. 1](#f0005){ref-type="fig"}A). Therefore, we hypothesized that p53 might participate in H~2~O~2~-induced myocardial necrosis by repressing the expression of ARC. To assess the role of p53 in myocardial necrosis, p53 was stably overexpressed in cardiomyocytes by adenoviral infection ([Fig. 6](#f0030){ref-type="fig"}B). Our result showed that overexpression of p53 sensitized cardiomyocytes to undergo necrosis upon H~2~O~2~ exposure (100 μM) ([Supplementary Fig. 3A and Supplementary Fig. 3B](#s0160){ref-type="sec"}). Conversely, the knockdown of p53 inhibited H~2~O~2~-induced necrosis in cardiomyocytes ([Fig. 6](#f0030){ref-type="fig"}F and [Supplementary Fig. 3C](#s0160){ref-type="sec"}). These results showed that p53 participated in H~2~O~2~-induced myocardial necrosis. Next, we examined the link between p53 and ARC in the regulation of necrosis. Our results showed that the overexpression of p53 could significantly decrease the expression levels of ARC in cardiomyocytes at both the mRNA and protein levels ([Fig. 6](#f0030){ref-type="fig"}B and D). Conversely, the knockdown of p53 could rescue the expression of ARC at both the mRNA and protein levels in cardiomyocytes exposed to H~2~O~2~ (500 μM) ([Fig. 6](#f0030){ref-type="fig"}C and E). The overexpression of p53 sensitized cardiomyocytes to undergo necrosis when exposed to H~2~O~2~ (100 μM), but either the simultaneous overexpression of ARC or the knockdown of CypD could attenuate the sensitivity of cardiomyocytes to oxidative stress ([Supplementary Fig. 3D-3G](#s0160){ref-type="sec"}). Furthermore, the knockdown of p53 inhibited necrosis induced by H~2~O~2~ exposure and this inhibition was abolished either by the simultaneous knockdown of ARC or by the overexpression of CypD ([Fig. 6](#f0030){ref-type="fig"}G and H). Taken together, these results demonstrated that p53 promoted myocardial necrosis by repressing ARC expression at the transcriptional level.Fig. 6**p53 promoted myocardial necrosis by transcriptionally repressing ARC expression.** (A) p53 protein levels in cardiomyocytes treated with 500 μM H~2~O~2~ for the indicated time were detected by Western blotting. (B) Overexpression of p53 by adenovirus decreased the protein levels of ARC in cardiomyocytes. (C) Knockdown of p53 partially recovered the protein levels of ARC in cardiomyocytes exposed to 500 μM H~2~O~2~. (D) Overexpression of p53 decreased the mRNA levels of ARC. (E) Knockdown of p53 partially recovered the mRNA levels of ARC in cardiomyocytes exposed to 500 μM H~2~O~2~. (F) Knockdown of p53 inhibited necrosis in cardiomyocytes exposed to 500 μM H~2~O~2~. Necrosis was detected by PI assay. Error bars represent SEM; \*P \< 0.05 vs control. (G) Knockdown of p53 inhibited necrosis which was abolished by simultaneous knockdown of ARC. Necrosis was detected by PI assay. Error bars represent SEM; \*P \< 0.05 vs control. (H) Knockdown of p53 inhibited necrosis which was abolished by simultaneous overexpression of CypD. Necrosis was detected by PI assay. Error bars represent SEM; \*P \< 0.05 vs control.Fig. 6

3.6. ARC protected cardiomyocytes from necrotic cell death in the heart {#s0130}
-----------------------------------------------------------------------

After validating the role of ARC in H~2~O~2~-induced necrosis *in vitro*, we further investigated the role of ARC in the pathogenesis of cardiac infarction in a mouse model of I/R^14^. First, we examined the protein levels of ARC and p53 in the mice ischemic heart tissues. Our results showed that the protein levels of ARC were decreased but the protein levels of p53 were increased significantly in a time dependent manner in the ischemic heart tissues ([Fig. 7](#f0035){ref-type="fig"}A). Next, we examined whether ARC inhibited myocardial necrosis in the mouse I/R model. Our results showed that the adenovirus harboring, ARC overexpressing mice group had significantly reduced myocardial necrosis compared to the negative control group, as indicated by the PI staining ([Fig. 7](#f0035){ref-type="fig"}B and C) and by the LDH activity in the serum ([Fig. 7](#f0035){ref-type="fig"}D) after the I/R surgery. Moreover, the myocardial infarct size was also reduced in the ARC overexpressing mice group compared to the negative control group ([Fig. 7](#f0035){ref-type="fig"}E) during cardiac I/R damage. These results demonstrated that ARC protected cardiomyocytes from necrosis during the cardiac I/R injury.Fig. 7**ARC protected cardiomyocytes from necrotic cell death in the heart.** (A) The protein levels of ARC and p53 in the ischemic heart tissues for the indicated ischemia time were detected by Western blotting. (B) Overexpression of ARC by adenovirus infection attenuated myocardial necrosis during cardiac ischemia/reperfusion (I/R). Mice were subjected to 30 min of LAD ligation followed by 3 h of reperfusion (n = 5/group). Propidium iodide (PI) was injected into the mice to label necrotic cells after the I/R. Representative images of ventricular myocardium sections are shown. Red, PI-positive cardiomyocyte nuclei; blue, 4′,6-diamidino-2-phenylindole--stained nuclei; green, α-actinin; scale bar, 40 µm. (C) Quantitative analysis of PI-positive cells is shown. Error bars represent SEM; \*P \< 0.05 vs control. (D) Serum LDH was measured 3 h after reperfusion. Error bars represent SEM; \*P \< 0.05 vs control. (E) The ratios of area at risk (AAR) to left ventricular (LV) area and infarct (INF) area to AAR are shown (n = 5/group). Error bars represent SEM; \*P \< 0.05 vs control; Scale bar, 1 mm.Fig. 7

It is well known that myocardial necrosis induces robust inflammation which further damages the heart during I/R injury [@bib46], [@bib47]. To assess the role of ARC in the inflammatory response after I/R injury, we quantified the expression levels of pro-inflammatory markers. Our results showed that pro-inflammatory markers, such as IL-1β, TNF-α and IL-6, were upregulated significantly during the I/R injury, but expression of these markers was attenuated significantly in the ARC overexpressing mice group compared to the negative control group ([Fig. 8](#f0040){ref-type="fig"}A, B and C).Fig. 8**ARC alleviated the inflammation caused by I/R injury and improved the long-term function of the heart after I/R injury.** The levels of (A) interleukin (IL)-1β, (B) tumor necrosis factor-α (TNF-α) and (C) interleukin (IL)--6 were analyzed in mice I/R heart tissues by Q-PCR. Error bars represent SEM; \*P \< 0.05 vs control. Mice were treated as described in [Fig. 7](#f0035){ref-type="fig"}C (n = 5/group). (D) Representative photomicrographs show Masson trichrome staining for collagen. (E) The ratios of collagen area were shown. Error bars represent SEM; \*P \< 0.05 vs control; Scale bar, 60 µm. Echocardiographic analysis of left ventricular dimensions and cardiac function in mice (n = 5/group) 2 weeks after surgery; (F) EF, ejection fraction of left ventricular diameter; (G) FS, fractional shortening of left ventricular diameter; (H) LVIDd, diastolic left ventricular internal diameters. Error bars represent SEM; \*P \< 0.05 vs control.Fig. 8

Long-term cardiac function and remodeling has been considered an important criterion for cardio-protective strategies. Fibrosis of the myocardium is closely associated with cardiac remodeling and exacerbates the deterioration of heart function after I/R injury [@bib48]. Our results showed that the collagen areas were reduced two weeks after I/R injury in the ARC overexpressing mice compared to the negative control group ([Fig. 8](#f0040){ref-type="fig"}D and E). Moreover, the ARC overexpressing mice group had improved cardiac function as shown by preservation of the ejection fraction (EF) and fractional shortening (FS) and by a decrease in heart chamber dimensions after myocardial I/R injury. ([Fig. 8](#f0040){ref-type="fig"}F, G and H). Taken together, these results demonstrated that ARC prevented myocardial necrosis and reduced the infarcted areas of the heart exposed to I/R injury in mice. Moreover, ARC also attenuated the inflammation induced in response to necrosis and improved long-term heart function after I/R injury in mice hearts. Our findings revealed a significant role for ARC in regulating the myocardial necrosis that suggests ARC as a potential therapeutic target for cardio-protection during ischemia and oxidative stress-related cardiac diseases.

4. Discussion {#s0135}
=============

Necrosis is the major form of cell death during myocardial I/R injury [@bib1], [@bib3]. Understanding the underlying molecular mechanisms of necrosis will benefit clinical practice in protecting cardiomyocytes from I/R injury. In this study, we reported the pivotal role of ARC in regulating myocardial necrosis induced by oxidative stress. Protein levels of ARC significantly decreased in H~2~O~2~-induced necrosis and overexpression of ARC attenuated necrosis both *in vitro* and *in vivo* utilizing cardiomyocytes and the mouse model of I/R injury. Moreover, the inhibition of necrosis by ARC was critically dependent upon ARC localization to mitochondria. Mechanistically, ARC inhibited the opening of mPTP by targeting CypD in H~2~O~2~-induced necrosis in cardiomyocytes. Furthermore, we also confirmed that p53 was the upstream regulator of ARC in H~2~O~2~-induced necrosis and promoted myocardial necrosis by transcriptional suppression of ARC expression.

ARC has been reported to exert its strong cardio-protective properties through the inhibition of apoptosis. ARC binds to caspase-8 and caspase-2 through its CARD domain and inhibits apoptosis initiation [@bib24], [@bib25], [@bib26]. ARC can also preserve mitochondrial integrity and prevents cytochrome c release by inhibiting Bax in cardiomyocytes [@bib49]. Our data also showed that ARC significantly inhibited H~2~O~2~-induced apoptosis in cardiomyocytes and confirmed previously published results [@bib31] ([Supplementary Fig. 2A](#s0160){ref-type="sec"}). Although the cardio-protective role of ARC has been revealed in apoptosis, the function of ARC remains unknown in necrosis. Necrotic cell death has been shown to be involved in human cardiac diseases and contributes several-fold more to disease pathogenesis than apoptosis [@bib50]. The well-established concept of programmed necrosis has drawn more attention toward targeting necrosis in cardiac pathologies [@bib51], [@bib52]. Our present work has demonstrated the central role of ARC in the inhibition of oxidative stress-induced necrosis.

mPTP is a nonspecific pore in the inner mitochondrial membrane. The prolonged opening of mPTP usually converts the mitochondria from organelles that support cell survival to those that actively induce apoptotic and necrotic cell death [@bib53]. There is increasing evidence that mPTP opening is of critical importance during cardiac I/R injury [@bib16], [@bib53]. Therefore, understanding the regulation of mPTP opening is crucial for clinical cardio-protection strategies. It has been reported that CypD is localized in the mitochondrial matrix but under oxidative stress it trans-locates to the inner mitochondrial membrane, allowing CypD to bind to ANT, the major pore-formation element that induces the opening of mPTP [@bib54], [@bib55]. CypD exhibits peptidyl prolyl cis/trans isomerase (PPIase) activity, which causes a conformational change in ANT that converts it into a nonspecific pore [@bib53]. This activity of CypD is regulated by either posttranslational modification or protein-protein interactions. For instance, it has been reported that acetylation of CypD at lysine 166 promotes age-related cardiac hypertrophy by regulating the mPTP opening, which can be reversed by SIRT3-mediated deacetylation of CypD [@bib21]. HAX-1 has been reported to regulate the activity of CypD through interference with CypD binding to a chaperon protein in mitochondria, leaving CypD prone to degradation [@bib20]. However, we could not detect significant changes in the protein levels of CypD in both *in vitro* and *in vivo*. Therefore, our results suggested that ARC could possibly prevent CypD translocation to the mPTP complex from the mitochondrial matrix, keeping the mPTP pore inactive. The activation of JNK has been reported to promote the activity of CypD and mPTP opening [@bib56]. It has also been reported that ARC inhibits JNK activation by specific interaction with JNK1 and JNK2 in hepatic cells [@bib57]. Additionally, ARC has also been reported as an inhibitor of TNF-α-mediated necrosis in which ARC interferes with recruitment of RIP1, a critical mediator of TNF-α-induced necrosis [@bib27]. RIP1 has been reported as a central molecule for the initiation of multiple pathways that can contribute in necrotic cell death. For instance, RIP1 can disrupt the interaction between ANT and CypD, and impairs the function of ANT and increases ROS production [@bib58], [@bib59]. However, there needs to be further exploration into whether ARC inhibits CypD through the JNK pathway or through interference with recruitment of RIP1 and/or RIP1 disruption of CypD in cardiomyocytes during oxidative stress.

The transcription factor p53 has been reported as a master regulator of the cardiac transcriptome and an important modulator during I/R injury [@bib32], [@bib60]. In our previous work, we found that the ARC promoter region contains two p53 binding sites, and p53 represses the expression of ARC at the transcriptional level during apoptosis induction [@bib31]. p53 has also been shown to induce necrosis in MEF cells [@bib23]. However, little is known about the role of p53 in myocardial necrosis. Our results highlighted that p53 promoted myocardial necrosis by the transcriptional suppression of ARC in cardiomyocytes.

It has been reported that p53 could directly interact with CypD in MEF cells [@bib23]. In our work, we found that ARC could regulate necrosis by targeting CypD, and p53 suppressed the expression of ARC at the transcriptional level to initiate necrosis. It is well known that ARC is abundant exclusively in terminally differentiated cells, for instance, cardiomyocytes and skeletal muscle cells, as well as some cancer cell lines, and is an important protein for maintaining cell survival [@bib24], [@bib61]. The protein levels of ARC in cardiomyocytes determined the switching point from cell survival to cell death. Therefore, we reasoned that the transcriptional suppression of ARC by p53 was an important step for necrosis initiation in cardiomyocytes. However, whether p53 could directly target CypD in cardiomyocytes needs to be explored further.

5. Conclusion {#s0140}
=============

In summary, our data revealed the pivotal role of ARC in myocardial necrosis and delineated the p53-ARC-CypD/mPTP central necrosis pathway, which can provide a potential therapeutic avenue for ischemia and oxidative stress-related cardiac diseases.

Appendix A. Supplementary material {#s0160}
==================================

Supplementary Fig. 1(A) Necrosis and apoptosis were detected simultaneously in cardiomyocytes exposed to 500 μM H~2~O~2~ or 100 μM H~2~O~2~ at the indicated time by the PI and TUNEL assays. Representative photomicrographs show the PI and TUNEL double staining in the cardiomyocytes. (B) Statistical data showed the ratio of TUNEL positive cells and PI positive cells to the total cardiomyocytes exposed to 500 μM H~2~O~2~ or 100 μM H~2~O~2~. Error bars represent SEM; \*P \< 0.05. (C) Forced expression of ARC prevented H~2~O~2~-induced necrosis in cardiomyocytes exposed to 500 μM H~2~O~2~ for 12 h compared to the control. (D) Knockdown of ARC increased H~2~O~2~-induced necrosis in cardiomyocytes exposed to 100 μM H~2~O~2~ for 12 h compared with the control. Necrosis was indicated by LDH release assay. Error bars represent SEM; \*P \< 0.05.Supplementary Fig. 1

Supplementary Fig. 2(A) ARC overexpression inhibited apoptosis in cardiomyocytes exposed to 100 μM H~2~O~2~ for 24 h. Apoptosis was detected by TUNEL assay. Error bars represent SEM; \*P \< 0.05 vs control. (B) CsA (5 μM) delayed the loss of TMRE fluorescence in cardiomyocytes exposed to 500 μM H~2~O~2~ compared with the control. Error bars represent SEM; \*P \< 0.05 vs control.Supplementary Fig. 2

Supplementary Fig. 3(A) Overexpression of p53 sensitized cardiomyocytes to undergo necrosis when exposed to 100 μM H~2~O~2~. Necrosis was indicated by LDH release assay. Error bars represent SEM; \*P \< 0.05 vs control. (B) Overexpression of p53 sensitized cardiomyocytes to undergo necrosis when exposed to 100 μM H~2~O~2~; Necrosis was detected by PI assay; Error bars represent SEM; \*P \< 0.05 vs control. (C) Knockdown of p53 inhibited necrosis in cardiomyocytes exposed to 500 μM H~2~O~2~. Necrosis was indicated by LDH release assay; Error bars represent SEM; \*P \< 0.05 vs control. (D) Overexpression of p53 sensitized cardiomyocytes to undergo necrosis which was prevented by simultaneous overexpression of ARC; Necrosis was detected by PI assay; Error bars represent SEM; \*P \< 0.05 vs control. (E) Overexpression of p53 sensitized cardiomyocytes to undergo necrosis which was prevented by simultaneous knockdown of CypD; Necrosis was detected by PI assay; Error bars represent SEM; \*P \< 0.05 vs control. (F) Overexpression of p53 sensitized cardiomyocytes to undergo necrosis which was prevented by simultaneous overexpression of ARC; Necrosis was indicated by LDH release assay; Error bars represent SEM; \*P \< 0.05 vs control. (G) Overexpression of p53 sensitized cardiomyocytes to undergo necrosis which was prevented by simultaneous knockdown of CypD; Necrosis was indicated by LDH release assay; Error bars represent SEM; \*P \< 0.05 vs control.Supplementary Fig. 3

Supplementary Fig. 4Full gel exposure of the Western blot results indicating the expression of the ARC during necrosis induction. (B) Full gel exposure of the Western blot results indicating the different distribution of ARC^T149A^ in the cytosol and mitochondria. (C) Full gel exposure of the Western blot results indicating the expression of ARC in the ischemic heart tissues.Supplementary Fig. 4
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